This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Biocomo Inc., Mie University. Active years: 2014-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2017
Title: Junpei Ohtsuka: Innovator in Viral Vector Technology
Introduction
Junpei Ohtsuka is a notable inventor based in Mie, Japan. He has made significant contributions to the field of viral vector technology, particularly in the development of vaccines and gene transfer methods. With a total of 2 patents, Ohtsuka's work has the potential to impact medical science and therapeutic applications.
Latest Patents
Ohtsuka's latest patents include a vaccine prepared utilizing a human parainfluenza virus type 2 vector. This invention discloses a virus vector in which a gene encoding an antigenic polypeptide is integrated into the human parainfluenza virus type 2 gene. The antigenic polypeptide is expressed as a fusion protein with a viral structural protein, allowing for efficient delivery to target cells. Another significant patent is a method for producing a virus vector for gene transfer. This invention describes a cell system that can stably express the F protein and a method for producing an F gene-deficient virus using a specific host cell.
Career Highlights
Throughout his career, Junpei Ohtsuka has worked with various organizations, including Biocomo Inc. and Mie University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Ohtsuka has collaborated with notable colleagues such as Masayuki Fukumura and Mitsuo Kawano. These partnerships have likely enriched his research and led to innovative developments in his field.
Conclusion
Junpei Ohtsuka's work in viral vector technology exemplifies the importance of innovation in medical science. His patents and collaborations highlight his commitment to advancing healthcare solutions through research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile